IXOPAY and Aperia Compliance Merge to Extend Advanced Payment Data Security to Merchant Acquirers and Merchants of All Sizes, Worldwide
Merger combines IXOPAY's enterprise-grade capabilities in payment orchestration and tokenization with Aperia Compliance's PCI DSS Level 3 and 4 solutions.
TULSA, OKLAHOMA / ACCESSWIRE / December 4, 2024 / IXOPAY, a leading payments technology provider handling more than $35 billion in payment volume through its enterprise-grade payment orchestration platform, announced today that it has merged with Aperia Compliance, a subsidiary of Aperia Solutions and a leading firm in Payment Card Industry Data Security Standard (PCI DSS) data validation and risk management. Serving more than 100 merchant acquirers, Aperia Compliance will operate as "Aperia Compliance, an IXOPAY company."
IXOPAY offers enterprise-grade PCI DSS Level 1 and 2 solutions powered by advanced tokenization. Paired with Aperia Compliance's robust PCI DSS Level 3 and 4 solutions-including PCI Apply 4.0 and the new 6.4.3 product-the combined offering aims to deliver a scalable, end-to-end solution enabling merchants, independent sales organizations (ISOs), and payment processors to comply with global data security standards, streamline operations, and drive revenue growth.
"Today's merger with Aperia Compliance enables IXOPAY to extend its capabilities and seeks to provide merchant acquirers of all sizes with powerful tools to navigate updated PCI DSS Version 4.0 requirements and secure their payment systems," said Brady Harris, CEO of IXOPAY. "By combining Aperia Compliance's PCI DSS Level 3 and 4 solutions with our enterprise-grade payments orchestration, we're expanding our platform with the goal of further simplifying compliance, enhancing security, and supporting businesses as they adapt to the evolving payments landscape."
Customers of both companies will now have access to the entire product suite. IXOPAY customers will have access to Aperia Compliance's PCI DSS Level 3 and 4 validation and risk management solutions, which include self-assessment questionnaire assistance, vulnerability scanning, multilingual support, integrated security solutions, data breach protection, merchant education, and reporting and analytics. Aperia Compliance customers-ISOs, processors, banks, and payfacs-gain access to IXOPAY's PCI DSS Level 1 and 2 tokenization and payment orchestration capabilities, along with fraud prevention, automated account updater, 3-D Secure authentication, point-to-point encryption, network token security, and detailed compliance reporting with universal tokens.
"The strategic merger of Aperia Compliance and IXOPAY creates a broader set of tools that enable businesses to compete in the fast-paced payments space," said Kevin Mokarow, Chairman and CEO of Aperia Solutions and senior advisor to the IXOPAY board of directors. "By combining strengths, we're extending IXOPAY's capabilities to small and medium-sized businesses worldwide, aiming to help merchants, ISOs, and processors reduce errors, prevent fraud, and streamline operations for sustainable growth."
The merger with Aperia Compliance is the latest transaction announced by IXOPAY, a portfolio company of K1 Investment Management, following IXOPAY's recent merger with TokenEx and a slate of new executive appointments, including CEO Brady Harris.
"This is another step on the way to creating a payments industry leader," said Tarun Jain, Principal at K1 Investment Management. "Earlier this year, the integration of TokenEx's advanced tokenization technology positioned IXOPAY as a continued innovator in the world of payment data security. With the addition of Aperia Compliance's PCI products, IXOPAY continues to strengthen its platform and help redefine payment operations for businesses worldwide."
Aperia Compliance's management team is continuing with the business under IXOPAY. Aperia Solutions is not a part of the merger and will continue to operate under the Aperia brand.
Media Contact
Mills Forni, Verdis
About IXOPAY
IXOPAY is a leading provider of enterprise-grade payment orchestration, providing a fully integrated platform and flexible payment optimization modules to businesses around the world. With a single API and scalable payments architecture, IXOPAY empowers businesses to streamline, secure, and increase the resilience of their payment systems. Learn more at www.ixopay.com.
About Aperia Compliance
Aperia Compliance, an IXOPAY company, is a leader in Payment Card Industry (PCI) validation and risk management, providing PCI Level 3 and 4 compliance for ISOs, payment processors, and small and medium-sized businesses. Learn more at www.aperia.com/proPCI - Aperiaducts/pci
Contact Information
Mills Forni
Verdis
mills@verdis.xyz
Related Images
|
Source: IXOPAY
View the original press release on accesswire.com
IXOPAY
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Maxon One Winter Release Brings Holiday Cheer from Concept to Render4.12.2024 10:20:00 CET | Press release
Defy cookie-cutter conventions, create the magic of snowfall, and craft festive figures with updates in Cinema 4D, ZBrush, Red Giant and Redshift; master chef of digital delectables Patrick 4D gets in on the fun with gingerbread delights for all BAD HOMBURG, GERMANY / ACCESSWIRE / December 4, 2024 / Maxon, maker of powerful, approachable software solutions for content creators working in 2D and 3D design, motion graphics, visual effects, and more, today released updates across its Maxon One product suite, with new features in Cinema 4D, Redshift, ZBrush and ZBrush for iPad, and Red Giant. The release fulfills artists' holiday wishlists with new capabilities that enhance everyday workflows and improve quality of life for artists, animators, VFX professionals, and studios. Image courtesy of Patrick 4D Whether it's crafting unique models using brand new Cinema 4D Booleans that give cookie-cutter a whole new meaning or bringing a dazzling snowfall to life with Cinema 4D Particles, Maxon On
Autobrains and JOYNEXT Revolutionize Smart Camera Solution Powered by Autobrains’ Affordable Safety ADAS Software4.12.2024 04:00:00 CET | Press release
Driving the Future of Safety: Cost-Effective, AI-Powered ADAS Solutions for Global OEMs MUNICH, GERMANY | DRESDEN, GERMANY | TEL AVIV, ISRAEL / ACCESSWIRE / December 4, 2024 / Autobrains, a leader in automotive artificial intelligence (AI), has joined forces with JOYNEXT, a global automotive Tier-1 supplier and development partner to renowned car manufacturers for over 20 years, to offer their groundbreaking Smart Camera ADAS solution. The camera hardware and optimized control software, provided by JOYNEXT, is powered by Autobrains' Affordable Safety ADAS software. The single-box Smart Camera solution, optimized for cost-effective Advanced Driver Assistance Systems (ADAS), was designed to meet the evolving needs of global Original Equipment Manufacturers (OEMs). This compact system simplifies integration, reduces costs, and ensures regulatory compliance without sacrificing performance. With ever increasing global regulations, smart cameras are a must-have in new build vehicles. The joi
Japan Maritime Defense Force Selects SeaGuardians From GA-ASI3.12.2024 14:00:00 CET | Press release
SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / The Japan Maritime Self-Defense Force (JMSDF) has selected the General Atomics Aeronautical Systems, Inc. (GA-ASI) SeaGuardian® Remotely Piloted Aircraft (RPA) systems for its Long Endurance Unmanned Aerial Vehicle program. This follows JMSDF use of SeaGuardian since May 2023 as part of its Medium-Altitude, Long Endurance (MALE) RPA System Trial Operations Project. SeaGuardian has been used by JMSDF to conduct various tests including whether unmanned aircraft can supplant some of the missions currently accomplished with manned aircraft. SeaGuardian is a MALE RPA system that can fly for 24 hours or more, depending on the configuration. GA-ASI has strengthened its Maritime Wide Area Surveillance (MWAS) for Japan with Optix+, which gathers information from the SeaGuardian sensors, as well as other data sources, displaying the full picture of surveillance information for its operator. This functionality makes it easy to task and direct its In
15 Companies Pitch Their Capabilities at GA-ASI’s Blue Magic Netherlands2.12.2024 13:00:00 CET | Press release
Nov. 19 Event Hosted by GA-ASI and Supported by Lockheed Martin Ventures and Brainport Attracts Cross-Section of Netherlands' High-Tech Sector SAN DIEGO, CA / ACCESSWIRE / December 2, 2024 / On November 19, 2024, General Atomics Aeronautical Systems, Inc. (GA-ASI) hosted its first Blue Magic Netherlands (BMN) event in Eindhoven, the Netherlands. Approximately 200 people attended the event that provided Dutch businesses with an opportunity to present their capabilities to GA-ASI and other companies interested in possible collaborations. GA-ASI was joined for the event by the Netherlands Ministry of Economic Affairs, the Netherlands Ministry of Defence, Lockheed Martin Ventures, Brainport Development, Brabant Development Agency (BOM), the Netherlands Industries for Defence & Security (NIDV), and SpaceNED. At this event, GA-ASI and its partners heard first-hand from Dutch companies about the important capabilities they are developing. The process started in July when GA-ASI put out an ope
BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide2.12.2024 03:05:00 CET | Press release
VANCOUVER, BC / ACCESSWIRE / December 2, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, announces the development of a sublingual thin-film oral dissolvable film (ODF) for Semaglutide, internally identified as BNT24005. This innovative product is intended to address limitations of existing administration methods for a therapeutic developed by Novo Nordisk, with the aim of improving patient accessibility and convenience. This product is currently under development and remains subject to regulatory review and approval. Semaglutide: A Proven Therapeutic Leader Semaglutide, developed by Novo Nordisk and marketed under brand names such as Ozempic® and Wegovy®, has revolutionized treatment for Type 2 diabetes and obesity. By mimicking glucagon-like peptide-1 (GLP-1), it enhances insulin secretion, reduces appetite, and slows gastric emptying, offering powerful tools for glycemi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom